Partial Mayo score

Biomarker1 paper1 finding

Humans1

Interventions

1

GLP-1 receptor agonists

downin humans1Low certainty

1 study

GLP-1 receptor agonists decrease partial Mayo score in humans (from 5.8 to 2.1 vs 4.6 in controls).
Humansin patients with UC12 weeks
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study · Inflammatory bowel diseases · 21 Aug 2026

GLP-1 receptor agonists →

Latest

1

Inflammatory Bowel DiseasesHumans21 Aug

GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study

GLP-1 receptor agonists